WILMINGTON, NC (WWAY) — Novant Health New Hanover Regional Medical Center is offering the Barostim implant for heart failure patients. The first local recipient, Chuck Moon, says the results have been ...

When medication stops working for people with congestive heart failure there are few options. A few months ago, Joe Knox couldn't take a simple walk due to his congestive heart failure. "I couldn't ...

CVRx, Inc. announced at the Technology and Heart Failure Therapeutics (THT) conference that new real-world evidence demonstrates significant reductions in hospital visits and length of stay after ...

Chuck Moon, a congestive heart failure patient, experienced significant improvement in his quality of life after receiving a Barostim device implant. The Barostim device is a new technology that acts ...

MINNEAPOLIS, July 16, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) ...

MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (CVRX) (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services ...

ALBANY, N.Y. — The Albany Med Health System has successfully implanted the world’s first FDA-approved heart failure device designed to treat patients who have had little to no success with other ...

CVRx announced today the launch of its second-generation programmer that is compatible with all Barostim implantable systems. FDA approved the new programmer in April. The Minneapolis, MN-based ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular ...

CVRx (CVRX) stock rebounds as Humana (HUM) issues first coverage for the company's Barostim heart failure device, effective ...